Influence of body mass index and self-administration of hCG on the outcome of IVF cycles: A prospective cohort study

References

• Abdalla HI, Ah-Moye M, Brinsden P, Howe DL, Okonofua F, Craft I. The effect of the dose of human chorionic gonadotrophin and the type of gonadotrophin stimulation on oocyte recovery rates in an in vitro fertilisation programme. Fertility and Sterility 1987; 46: 958–963
   Google Scholar
• Al-Hassan SN, Fishel S, Fleming S, Thornton S, Akram M, Dowell K, Ndukwe G, Thompson K, Maynard P. Effect of plasma concentration of hCG on pregnancy outcome. Human Reproduction (Supplement) 1997; 12: 18A–18A
   Web of Science ®Google Scholar
• Asch RH, Li HP, Yovich JL, Katayama KP, Balamaceda JP, Rojas FJ, Stone SC. Failed oocyte retrieval after lack of human chorionic gonadotrophin administration in assisted reproductive technology. Fertility and Sterility 1992; 58: 361–365
   PubMed Web of Science ®Google Scholar
• Bray GA. Obesity and reproduction. Human Reproduction 1997; 12(Supplement 1)26–32
   PubMedGoogle Scholar
• Chong AP, Rafael RW, Forte CC. Influence of weight in the induction of ovulation with human menopausal gonadotrophin and human chorionic gonadotrophin. Fertility and Sterility 1986; 46: 599–603
   PubMed Web of Science ®Google Scholar
• Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Human Reproduction 1998; 13: 1502–1505
   PubMed Web of Science ®Google Scholar
• Crosignani PG, Ragni G, Parazzini F, Wyssling H, Lambrosa G, Perotti L. Anthropometric indicators and response to gonadotrophin for ovulation induction. Human Reproduction 1994; 9: 420–423
   PubMed Web of Science ®Google Scholar
• Damewood MD, Shen W, Zacur HA, Schlaff WD, Rock JA, Wallach EE. Disappearance of exogenously administered human chorionic gonadotrophin. Fertility and Sterility 1989; 52: 398–400
   PubMed Web of Science ®Google Scholar
• Duerenberg P, Westgate JA, Seidell JC. Body mass index as a measure of body fatness: age and sex specific prediction formulas. British Journal of Nutrition 1991; 65: 105–114
   PubMed Web of Science ®Google Scholar
• Forman R, Fries N, Testart J, Belaisch-Allart J, Hazout A, Frydman R. Evidence for an adverse effect of elevated serum oestradiol concentration on embryo implantation. Fertility and Sterility 1988; 49: 118–122
   PubMed Web of Science ®Google Scholar
• Gildey-Baird AA, O'Neill C, Sinosich MY, Porter RN, Pike IL, Saunders DM. Failure of implantation in human in vitro fertilisation and embryo transfer patients: the effects of altered progesterone/oestrogen in humans and mice. Fertility and Sterility 1989; 45: 69–74
   Google Scholar
• Gleitcher N, Dudkewicz A, Pratt D. Biochemical pregnancies or heterophil antibodies. Fertility and Sterility 1992; 57: 1363–1366
   PubMed Web of Science ®Google Scholar
• Gray DS, Fujioka K. Use of relative weight and body mass index for the determination of adiposity. Journal of Clinical Epidemiology 1991; 44: 545–550
   PubMed Web of Science ®Google Scholar
• Grodstein F, Goldman MB, Cramer DW. Body mass index and ovulatory infertility. Epidemiology 1994; 5: 247–250
   PubMed Web of Science ®Google Scholar
• Hamilton-Fairley D, Kiddy D, Watson H, Paterson C, Franks S. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. British Journal of Obstetrics and Gynaecology 1992; 99: 128–131
   PubMedGoogle Scholar
• Isaacs JD, Magann EF, Martin RW, Chauham SP, Morrison JC. Obstetric challenges of massive obesity complicating pregnancy. Journal of Perinatology 1994; 14: 10–14
   PubMedGoogle Scholar
• Kirschner MA, Samojik E, Drejka M, Szmal E, Scheider G, Evtel N. Androgen-estrogen metabolism in women with upper body versus lower body obesity. Journal of Clinical Endocrinology and Metabolism 1990; 70: 473–479
   PubMed Web of Science ®Google Scholar
• Lashen H, Ledger W, Bernal AL, Barlow D. Extremes of body mass do not adversely affect the outcome of superovulation and in vitro fertilisation. Human Reproduction 1999; 14: 712–715
   PubMed Web of Science ®Google Scholar
• Levy T, Ben-Rafael Z. Pharmacokinetics of gonadotrophin therapy. Reproductive Medicine Reviews 1996; 5: 13–25
   Google Scholar
• Lewis CG, Graham NW, Wang RW, Mathews CD. Failure of body mass index to influence markedly the response to ovarian hyperstimulation in normal cycling women. Fertility and Sterility 1991; 53: 1097–1099
   Web of Science ®Google Scholar
• McClure N, McQuinn B, McDonald J. Body weight, body mass index and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome?. Fertility and Sterility 1992; 58: 622–624
   PubMed Web of Science ®Google Scholar
• Maier DB, Metzer DA. Slow secretion of exogenous gonadotrophins in the recruitment of human ovarian follicles. Fertility and Sterility 1991; 56: 783–785
   PubMedGoogle Scholar
• Mannaerts B, Geurts T, Oodink J. A randomised three-way crossover study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregynl®) after intramuscular and subcutaneous administration. Human Reproduction 1998; 13: 1461–1464
   PubMed Web of Science ®Google Scholar
• Mitchell GW, Rogers J. The influence of weight reduction on amenorrhea in obese women. New England Journal of Medicine 1953; 249: 835–837
   PubMed Web of Science ®Google Scholar
• Nader S, Albert SB. Study of the pharmacokinetics of human chorionic gonadotrophin and its relation to ovulation. Journal of In Vitro Fertilisation and Embryo Transfer 1990; 7: 114–117
   PubMedGoogle Scholar
• Ndukwe G, Thonton S, Fishel S, Dowell K, Al-Hassan S, Hunter A. Predicting empty follicle syndrome. Fertility and Sterility 1996; 66: 845–847
   PubMed Web of Science ®Google Scholar
• Ren SG, Braunstein GD. Human chorionic gonadotrophin. Seminars in Reproductive Endocrinology 1992; 10: 95–105
   Google Scholar
• Rich-Edwards JW, Goldman MB, Willet WC, Hunter DJ, Stampfer MJ, Colditz GA, Manson JE. Adolescent body mass index and infertility caused by ovulatory disorders. American Journal of Obstetrics and Gynecology 1994; 171: 171–177
   PubMed Web of Science ®Google Scholar
• Salha O, Nugent D, Dada T, Levett S, Jenner L, Kaufmann S, Sharma V. The relationship between follicular fluid aspirate volume and oocyte maturity in IVF treatment cycles. Human Reproduction 1998; 13: 1901–1906
   PubMed Web of Science ®Google Scholar
• Testart J, Frydman R. Minimum time lapse between luteinizing hormone surge or human chorionic gonadotrophin administration and follicular rupture. Fertility and Sterility 1982; 37: 50–53
   PubMed Web of Science ®Google Scholar
• Wabitsch M, Hauner H, Heinze E, Bochmann A, Benz R, Mayer H, Teller W. Body fat distribution and steroid hormone concentrations in obese adolescent girls before and after weight reduction. Journal of Clinical Endocrinology and Metabolism 1995; 80: 3469–3475
   PubMed Web of Science ®Google Scholar
• Waller DK, Mills JL, Simpson JL, Cunnigham GC, Conley MR, Lasserman MR, Rhoads CG. Are obese women at higher risk for producing malformed offspring?. American Journal of Obstetrics and Gynecology 1994; 170: 541–548
   PubMed Web of Science ®Google Scholar
• Wass P, Waldenström U, Rössner S, Hellberg D. An android body fat distribution in females impairs the pregnancy rate of in vitro fertilisation-embryo transfer. Human Reproduction 1997; 12: 2057–2060
   PubMed Web of Science ®Google Scholar
• Weissman A, Lurie S, Zalel Y, Goldchmit R, Sholam Z. Human chorionic gonadotrophin: pharmacokinetics of subcutaneous administration. Gynecological Endocrinology 1996; 10: 273–275
   PubMed Web of Science ®Google Scholar
• Wikland M, Borg J, Forsberg AS, Jacobsson H, Svalander P, Waldenstrom V. Human chorionic gonadotrophin self administered by the subcutaneous route to induce oocyte maturation in an in vitro fertilisation and embryo transfer programme. Human Reproduction 1995; 10: 1667–1670
   PubMed Web of Science ®Google Scholar
• World Health Organisation. WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. Cambridge University Press, Cambridge 1992
   Google Scholar
• Yen SSC, Llerena O, Little B, Pearson OH. Disappearance rates of endogenous luteinising hormone and chorionic gonadotrophin in man. Journal of Clinical Endocrinology and Metabolism 1968; 17: 63–69
   Google Scholar
• Zaadstra BM, Seidell JC, Van Noord P. Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. British Medical Journal 1993; 306: 484–487
   PubMed Web of Science ®Google Scholar
• Zegers-Hochschild F, Fernandez E, MacKenna A, Fabres C, Altieri E, Lopez T. The empty follicle syndrome: a pharmaceutical industry syndrome. Human Reproduction 1995; 10: 2262–2265
   PubMed Web of Science ®Google Scholar
• Zullo F, Di Carlo C, Pellicano M, Catizone C, Mastrantonio P, Nappi C. Superovulation with human follicle stimulating hormone: correlation with body mass index and body fat distribution. Gynecological Endocrinology 1996; 10: 17–21
   PubMed Web of Science ®Google Scholar